Govt Planning To Offer COVID Vaccines At Pvt Hospitals For Rs 250/Jab
The Health Ministry is supposedly planning to offer COVID-19 vaccines at private hospitals for inoculating people above 60 and over 45 having comorbidities from March 1. As a part of the upcoming vaccination drive, the vaccines will be available at Rs 250/dose in 20,000 hospitals. Initially, while only Serum Institue of India's Covisheld will be available at private hospitals, around 1,500 NABH and NBE accredited hospitals have sought… read-more
Tags: Covid Vaccination, Covid-19 Vaccine, Covishield vaccine, Serum Institute of India
Courtesy: The New Indian Express
Ghana 1st Country To Receive COVAX Vaccines; Gets 6L Jabs From India
West-African country Ghana became the first country to obtain vaccines under the COVAX initiative as it welcomed 6,00,000 doses of the AstraZeneca vaccine by Serum Institute of India on February 24. Delivered by UNICEF, the vaccines reached Ghana’s Kotoka International Airport as part of the initial wave of COVID-19 vaccines that COVAX is granting to 92 low/middle-income nations. Reportedly, Ghana’s will commence its phased vaccination drive… read-more
Tags: Ghana, COVAX, UNICEF, Serum Institute of India, AstraZeneca, Covid -19, vaccine
Courtesy: The Hindu
S. Africa Asks Serum Institute To Take Back AstraZeneca COVID Vaccine
The South African government has requested the Serum Institute of India to withdraw one million shots of its COVID-19 vaccine 'AstraZeneca'. The country has reportedly stopped the rollout of the vaccine after finding it provided only mild to moderate protection against the African variant of coronavirus. Moreover, South Africa will now use Johnson & Johnson’s vaccine for its health workers. Recently, on February 15, the WHO gave emergency… read-more
Tags: Covid Vaccine, Serum Institute of India, South Africa, AstraZeneca
Courtesy: The Wire
Pune Court Rejects Cutis' Suit Against Serum Institute Over "Covishield" Name
A Pune court has rejected Cutis Biotech’s claim seeking the Serum Institute of India to drop the use of trademark ‘Covishield’ for its COVID-19 vaccine. Rejecting Cutis’ application, the court observed that the company had approached it with "suppressed… read-more
Tags: Serum Institute of India, Cutis Biotech, COVISHIELD, lawsuit, trademark, civil court, High Court, Pune, Maharashtra
Courtesy: NDTV
SII Hopeful To Launch Its 2nd Vaccine 'COVOVAX' By June
The Serum Institute of India (SII) chief Adar Poonawalla on January 30 announced of hopefully launching ‘COVOVAX’ as the second COVID-19 vaccine in June 2021. Poonawalla also claimed that the Novavax vaccine that has partnered with the US is currently undergoing trials and has shown excellent efficiency. While DCGI approved vaccines Covishield and Covaxin were used in India, the COVOVAX would become the third vaccine developed by India if… read-more
Tags: Serum Institute of India, Adar Poonawalla, Covovax, Novavax, Coronavirus, Covid-19 Vaccine
Courtesy: Zee News
SII Awaits Govt Approval To Conduct Trials Of Novavax COVID Vaccine
The Serum Institute of India has applied to the Drugs Controller General of India seeking permission to conduct domestic trials of ‘Novavax’ coronavirus vaccine. Reportedly, the US-based company claimed that Novavax showed 89.3% and 60% effectiveness during the trials in the UK and Africa respectively. Earlier, Novavax and SII collaborated to produce 2 billion vaccine doses. Besides, Novavax has received around $388 million from the Coalition… read-more
Tags: Novavax, SII, Serum Institute of India, DCGI
Courtesy: Live Mint
SII Announces Compensation Of Rs 25 Lakh To Families Of Deceased
Pune-based the Serum Institute of India has announced a Rs 25-lakh compensation to the families of five deceased who lost their lives in the fire outbreak on January 21. Expressing his grief, SII CEO Adar Poonawalla said, "Extremely sorrowful day for all of us". Reportedly, four other people were evacuated from the SII's Manjari premises . Meanwhile, the SII and Maharashtra CM Uddav Thackary have assured that the accident will not affect… read-more
Tags: Serum Institute of India, SII, Fire at SII, Fire Outbreak, Pune
Courtesy: Times Now
Pune: Fire Breaks Out At New SII Campus At Manjari
Serum Institute of India's premises at Pune's Manjari witnessed a fire breakout in its new building on January 21. As per the fire brigade officials, 10 fire tenders have been deployed at the site, where the incident happened around 2:30 pm. However, officials confirmed that the affected building was "not directly connected to Covishield manufacturing". Meanwhile, the evacuation process is underway, and no casualties have been reported until… read-more
Tags: Serum Institute of India, Pune, Manjari, Covishield vaccine
Courtesy: The Indian Express
People May Not Have Option To Choose From COVID Vaccines, Hints Govt
Stating that no other country with two or more vaccines has given an option, the health ministry representative on January 12 hinted that India will not provide option to choose between COVID-19 vaccines. Addressing a press conference, Health Secretary Rajesh Bhushan said both the vaccines of India are equally safe and there is no risk. Reportedly, the government will procure 110 lakh doses from Serum Institute of India and 55 lakh doses from… read-more
Tags: Covid-19 Vaccine, Covaxin, Bharat biotech, Serum Institute of India
Courtesy: The Times of India
Govt Orders 11Mn Doses Of 'Covishield' At Rs 200/Dose From SII
Taking a step ahead towards the COVID-19 vaccination, the Centre has ordered the first set of 11 million doses of Serum Institute of India's 'Covishield' vaccine. Ordered at the cost of Rs 200 per dose, the doses are expected to vaccinate around 10 million frontline workers nation-wide. Reportedly, the Union will afford the vaccination cost for 30 million workers without charging the states. The government will roll-out the mass vaccination… read-more
Tags: Serum Institute of India, COVISHIELD, Adar Poonawalla, Covid Vaccination
Courtesy: Hindustan Times